ArticleScientific reports2026
A multi-scale hybrid ResNet-transformer with distance-aware learning for interpretable BI-RADS mammographic classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Timely and accurate classification of breast lesions is needed on mammograms, as it will enhance clinical decisions and reduce unnecessary biopsies. The study proposes a Multi-Scale Hybrid ResNet–Transformer with Distance-Aware Learning for interpretable BI-RADS mammographic classification. The model integrates the spatial representation strength of ResNet-50 with the contextual modeling capability of lightweight multi-head self-attention layers, forming a unified hybrid architecture. Distance-Aware Learning loss is introduced to account for the ordinal nature of BI-RADS categories, penalizing predictions based on their proximity to the true class. The stage of preprocessing includes CLAHE to enhance mammographic contrast, followed by balanced oversampling and controlled augmentations to address data imbalance. Further, the model is trained and evaluated, which indicates strong generalization across validation and test sets. The hybrid model achieved a test accuracy of 0.921, with a mean AUC of 0.987 on the test set. The model performs a per-class discriminability, with F1-scores above 0.92 for clinically critical BI-RADS 4–5 categories. Moreover, the feature-space visualization and Grad-CAM based visual explanations confirm that the model focuses on clinically relevant lesion regions, providing interpretable outputs aligned with radiologist’s reasoning. The proposed framework will provide a clinically meaningful and efficient approach to automated BI-RADS classification, and may support future computer-aided diagnostic workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.